Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
IPMJ-Iraqi Postgraduate Medical Journal. 2011; 10 (1): 24-32
in English | IMEMR | ID: emr-104814

ABSTRACT

The Recent Studies have reported outstanding results concerning medical expulsive therapy [MET] for distal ureterolithiasis in terms of stone expulsion and control of colic pain. While ureteral intracorporeal lithotripsy and extracorporeal shock wave lithotripsy are recognized to be effective. To evaluate the role of phosphodiesterase S inhibitor [tadalafil] 10 mg in conservative therapy for patients with lower ureteral stones. From December 2009 to October 2010, 60 consecutive symptomatic patients with juxtavesical unilateral lower ureterolithiasis from the urologic consultation department in Baghdad Medical City were caroled in this randomized prospective placebo controlled study [pilot study]. Patients were randomly divided into two groups, group 1 [n=30] and group 2 [n=30]. Group 1 was given tadalafil 10mg. Group 2 was given placebo. Tadalafil 10mg or placebo was administered once daily. The treatment duration was until stone expulsion or 14 days. During this period, all patients were evaluated weekly by US and serum creatine level, and were asked whether they experienced acute colic pain, to score the intensity of pain according to a visual analog scale, whether the calculus passed spontaneously, the day and time of stone expulsion, number of analgesic use, and any drug side effects. The mean stone size was 7.91mm for treatment group and 7.55mm for placebo group [p>0.05] The stone expulsion rate was 93% for treatment group and 67% for placebo group [P<0.05]. Mean expulsion time was 5.5 days for treatment group and 8.84 days for placebo group [P=0.00l]. Mean VAS was 3.9 for treatment group and 7.9 for placebo group [P<0.0001]. Mean number of indomethacin suppositories used was 1.33 for treatment group and 7.9 for placebo group [P<0.05]. The univariate analysis using Cox proportional hazard model revealed that only therapy and stone size proved to be significantly predictive factors of stone expulsion [P<0.0001 and 0.001] respectively, while gender and age did not have any predictive value. Although side-effects occurred more in patients who were given tadalafil 10mg, no significant side-effect was detected so as to require exclusion of a patient from the study. Medical Expulsive Therapy [MET] for lower ureterolithiasis with tadalafil during conservative treatment period is safe and effective as demonstrated by the absence of serious side effects and increased stone expulsion rate with early time. Also MET with tadalafil 10mg affords an outstanding control of pain for patients while waiting for stone expulsion

2.
JPMA-Journal of Pakistan Medical Association. 2004; 54 (1): 1-1
in English | IMEMR | ID: emr-175577
3.
PJMR-Pakistan Journal of Medical Research. 2002; 41 (1): 4-8
in English | IMEMR | ID: emr-60606

ABSTRACT

A study was conducted during the period September 1999 to August 2000 at Clinical Microbiology Laboratory, Public Health Division, National Institute of Health; Islamabad, Pakistan, to find out the incidence of Eriterobacteriaceae in nosocomial and community acquired infections. Two hundred OPD [out patient department] isolates and two hundred nosocomial isolates from different wards [Oncology, Post-operative surgical, Kidney transplant center / Urology wards and Intensive care unit] of Pakistan Institute of Medical Sciences [PIMS] Islamabad, Pakistan, were collected for the study. The bacterial strains were isolated from pus, sputum, blood, urine, pleural fluid, peritoneal fluid and cerebro- spinal fluid [CSF]. The isolates were identified on the basis of standard microbiological and biochemical techniques. The incidence of Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Proteus vulgaris Enterobacter cloacae and Citrobacter freundii was studied according to their distribution among different wards /nosocomial patients, specimens and age groups of patients


Subject(s)
Humans , Cross Infection/epidemiology , Cross Infection/microbiology , Community-Acquired Infections/epidemiology , Community-Acquired Infections/microbiology , Escherichia coli , Klebsiella pneumoniae , Proteus mirabilis , Proteus vulgaris , Enterobacter cloacae , Citrobacter freundii , Prevalence , Age Distribution
SELECTION OF CITATIONS
SEARCH DETAIL